Testing effectiveness (Phase 2)Study completedNCT01340027
What this trial is testing
Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder
Who this might be right for
Urologic DiseasesUrinary Bladder DiseasesUrological Manifestations+2 more
Astellas Pharma Europe B.V. 1,307